1. Home
  2. PCRX vs SLQT Comparison

PCRX vs SLQT Comparison

Compare PCRX & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • SLQT
  • Stock Information
  • Founded
  • PCRX 2006
  • SLQT 1999
  • Country
  • PCRX United States
  • SLQT United States
  • Employees
  • PCRX N/A
  • SLQT N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • SLQT Specialty Insurers
  • Sector
  • PCRX Health Care
  • SLQT Finance
  • Exchange
  • PCRX Nasdaq
  • SLQT Nasdaq
  • Market Cap
  • PCRX 1.2B
  • SLQT 735.8M
  • IPO Year
  • PCRX 2011
  • SLQT 2020
  • Fundamental
  • Price
  • PCRX $26.88
  • SLQT $4.56
  • Analyst Decision
  • PCRX Buy
  • SLQT Hold
  • Analyst Count
  • PCRX 10
  • SLQT 1
  • Target Price
  • PCRX $29.30
  • SLQT $4.00
  • AVG Volume (30 Days)
  • PCRX 892.8K
  • SLQT 1.1M
  • Earning Date
  • PCRX 02-27-2025
  • SLQT 02-14-2025
  • Dividend Yield
  • PCRX N/A
  • SLQT N/A
  • EPS Growth
  • PCRX N/A
  • SLQT N/A
  • EPS
  • PCRX N/A
  • SLQT N/A
  • Revenue
  • PCRX $694,957,000.00
  • SLQT $1,381,309,000.00
  • Revenue This Year
  • PCRX $5.14
  • SLQT $12.73
  • Revenue Next Year
  • PCRX $2.44
  • SLQT $14.03
  • P/E Ratio
  • PCRX N/A
  • SLQT N/A
  • Revenue Growth
  • PCRX 4.40
  • SLQT 28.72
  • 52 Week Low
  • PCRX $11.16
  • SLQT $1.08
  • 52 Week High
  • PCRX $31.67
  • SLQT $4.64
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 77.75
  • SLQT 62.24
  • Support Level
  • PCRX $25.06
  • SLQT $4.07
  • Resistance Level
  • PCRX $27.10
  • SLQT $4.60
  • Average True Range (ATR)
  • PCRX 1.45
  • SLQT 0.28
  • MACD
  • PCRX 0.28
  • SLQT -0.04
  • Stochastic Oscillator
  • PCRX 86.23
  • SLQT 84.09

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About SLQT SelectQuote Inc.

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

Share on Social Networks: